• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨泌乳素血症的自然史。

The natural history of macroprolactinaemia.

机构信息

Department of Pharmaceutical Sciences, Ritsumeikan University, 1-1-1 Nojihigashi, Kusatsu, Shiga, Japan.

出版信息

Eur J Endocrinol. 2012 Apr;166(4):625-9. doi: 10.1530/EJE-11-1007. Epub 2012 Jan 12.

DOI:10.1530/EJE-11-1007
PMID:22247016
Abstract

OBJECTIVE

Macroprolactinaemia is a condition in which serum prolactin (PRL) consists mainly of large molecular weight PRL (macroPRL). The aim of this study was to examine the natural history of macroprolactinaemia.

DESIGN AND PARTICIPANTS

Six hundred and fifty-four hospital workers participated in this study, including 27 subjects with macroprolactinaemia and 627 controls. MacroPRL and serum PRL concentrations were evaluated over a 4-year period. The ratio of macroPRL was examined by the polyethylene glycol (PEG) method and gel filtration chromatography. IgG-bound PRL and anti-PRL autoantibodies were examined by protein G and (125)I-PRL binding studies respectively.

RESULTS

Over the 4 years of the study, all 27 macroprolactinaemic subjects had persistent macroprolactinaemia without the development of raised free PRL, while none of the 627 controls developed macroprolactinaemia. The ratios of PEG-precipitable PRL and IgG-bound PRL did not significantly change, but (125)I-PRL binding ratios significantly increased. As a whole, total and free serum PRL concentrations did not significantly change in subjects with macroprolactinaemia over the 4-year period. However, hyperprolactinaemia developed in five of the 18 macroprolactinaemic subjects who were initially normoprolactinaemic along with an increase in anti-PRL autoantibody titres. One of the remaining nine macroprolactinaemic subjects who were initially hyperprolactinaemic showed a decrease in serum PRL concentrations, which occurred concomitantly with a decrease in the anti-PRL autoantibody titre.

CONCLUSIONS

Macroprolactinaemia may develop before middle age and is likely a chronic condition leading to hyperprolactinaemia.

摘要

目的

血清催乳素(PRL)主要由大分子泌乳素(macroPRL)组成的巨泌乳素血症是一种病症。本研究旨在研究巨泌乳素血症的自然史。

设计和参与者

本研究共有 654 名医院工作人员参与,包括 27 名巨泌乳素血症患者和 627 名对照。在 4 年的时间里,评估了 macroPRL 和血清 PRL 浓度。通过聚乙二醇(PEG)法和凝胶过滤色谱法检查了 macroPRL 的比例。通过蛋白 G 和(125)I-PRL 结合研究分别检查了 IgG 结合的 PRL 和抗 PRL 自身抗体。

结果

在研究的 4 年中,所有 27 名巨泌乳素血症患者均持续存在巨泌乳素血症,而无游离 PRL 升高,而 627 名对照中无一人发生巨泌乳素血症。PEG 沉淀 PRL 和 IgG 结合 PRL 的比例没有显著变化,但(125)I-PRL 结合比例显著增加。总的来说,在 4 年期间,巨泌乳素血症患者的总血清 PRL 和游离 PRL 浓度没有显著变化。然而,在最初正常的 18 名巨泌乳素血症患者中,有 5 名出现了高泌乳素血症,并伴有抗 PRL 自身抗体滴度升高。在最初高泌乳素血症的 9 名巨泌乳素血症患者中,有 1 名患者的血清 PRL 浓度下降,同时抗 PRL 自身抗体滴度下降。

结论

巨泌乳素血症可能在中年之前发生,并且可能是导致高泌乳素血症的慢性疾病。

相似文献

1
The natural history of macroprolactinaemia.巨泌乳素血症的自然史。
Eur J Endocrinol. 2012 Apr;166(4):625-9. doi: 10.1530/EJE-11-1007. Epub 2012 Jan 12.
2
Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers.巨泌乳素血症:一大群医院工作人员中的患病率及病因
Clin Endocrinol (Oxf). 2009 Nov;71(5):702-8. doi: 10.1111/j.1365-2265.2009.03570.x. Epub 2009 Mar 28.
3
Macroprolactinaemia in patients with hyperprolactinaemia: composition of macroprolactin and stability during long-term follow-up.高泌乳素血症患者的巨泌乳素血症:巨泌乳素的组成及其在长期随访中的稳定性。
Clin Endocrinol (Oxf). 2010 Dec;73(6):792-7. doi: 10.1111/j.1365-2265.2010.03880.x.
4
Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition.巨泌乳素血症:聚乙二醇沉淀试验的验证与应用及该病症的临床特征
Clin Endocrinol (Oxf). 1999 Jul;51(1):119-26. doi: 10.1046/j.1365-2265.1999.00757.x.
5
Macroprolactinaemia associated with prolactin adenoma.与催乳素腺瘤相关的巨泌乳素血症。
Hum Reprod. 2003 Apr;18(4):853-7. doi: 10.1093/humrep/deg172.
6
Characterization of big, big prolactin in patients with hyperprolactinaemia.高泌乳素血症患者中大大泌乳素的特征分析。
Clin Endocrinol (Oxf). 1992 Oct;37(4):365-72. doi: 10.1111/j.1365-2265.1992.tb02340.x.
7
Possible involvement of matrix metalloproteinase-3 in the pathogenesis of macroprolactinaemia in some patients with rheumatoid arthritis.基质金属蛋白酶-3 可能参与了某些类风湿关节炎患者的巨泌乳素血症的发病机制。
Eur J Endocrinol. 2013 Jul 6;169(2):203-9. doi: 10.1530/EJE-13-0170. Print 2013 Aug.
8
Coexistence of macroprolactinaemia and hyperprolactinaemia in women with oligo-/amenorrhoea is associated with high risk of pituitary adenomas.患有少/闭经的女性中,巨泌乳素血症与高泌乳素血症并存与垂体腺瘤的高风险相关。
Gynecol Endocrinol. 2014 May;30(5):385-7. doi: 10.3109/09513590.2014.887672. Epub 2014 Feb 17.
9
Characterization of macroprolactin and assessment of markers of autoimmunity in macroprolactinaemic patients.巨泌乳素血症患者中巨泌乳素的特征分析及自身免疫标志物评估
Clin Endocrinol (Oxf). 2009 Apr;70(4):599-605. doi: 10.1111/j.1365-2265.2008.03402.x. Epub 2008 Sep 2.
10
Macroprolactinaemia: a biological diagnostic strategy from the study of 222 patients.巨泌乳素血症:基于222例患者研究的生物学诊断策略
Eur J Endocrinol. 2015 Jun;172(6):687-95. doi: 10.1530/EJE-14-1073. Epub 2015 Mar 9.

引用本文的文献

1
Interactions Between Prolactin, Intracellular Signaling, and Possible Implications in the Contractility and Pathophysiology of Asthma.催乳素、细胞内信号传导之间的相互作用及其对哮喘收缩性和病理生理学的潜在影响
Int J Mol Sci. 2025 Jul 29;26(15):7332. doi: 10.3390/ijms26157332.
2
The Effect of Metformin on Pituitary Function in Postmenopausal Women with Subclinical Hypothyroidism and Macroprolactinemia: A Single-Center Prospective Case-Control Study.二甲双胍对亚临床甲状腺功能减退和巨泌乳素血症绝经后女性垂体功能的影响:一项单中心前瞻性病例对照研究
Pharmaceuticals (Basel). 2025 Jun 2;18(6):834. doi: 10.3390/ph18060834.
3
Macroprolactinemia: a mini-review and update on clinical practice.
巨泌乳素血症:临床实践的小型综述与更新
F S Rep. 2023 May 24;4(3):245-250. doi: 10.1016/j.xfre.2023.05.005. eCollection 2023 Sep.
4
Evaluation of autoantibodies and immunoglobulin G subclasses in women with suspected macroprolactinemia.评估疑似巨泌乳素血症女性的自身抗体和免疫球蛋白 G 亚类。
J Clin Lab Anal. 2020 Nov;34(11):e23456. doi: 10.1002/jcla.23456. Epub 2020 Jun 29.
5
High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: is it necessary to restart treatment?催乳素瘤停用卡麦角林后生化复发率高:是否有必要重新开始治疗?
Endocrine. 2020 Oct;70(1):143-149. doi: 10.1007/s12020-020-02388-0. Epub 2020 Jun 17.
6
Optimizing laboratory defined macroprolactin algorithm.优化实验室定义的大泌乳素算法。
Biochem Med (Zagreb). 2019 Jun 15;29(2):020706. doi: 10.11613/BM.2019.020706.
7
Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism.高催乳素血症和催乳素瘤管理中的争议问题——巴西内分泌与代谢学会神经内分泌学部门概述
Arch Endocrinol Metab. 2018 Mar-Apr;62(2):236-263. doi: 10.20945/2359-3997000000032.
8
Serum prolactin and macroprolactin levels among outpatients with major depressive disorder following the administration of selective serotonin-reuptake inhibitors: a cross-sectional pilot study.选择性5-羟色胺再摄取抑制剂给药后重度抑郁症门诊患者的血清催乳素和大催乳素水平:一项横断面初步研究。
PLoS One. 2013 Dec 2;8(12):e82749. doi: 10.1371/journal.pone.0082749. eCollection 2013.